Sign Up to like & get
recommendations!
0
Published in 2017 at "Cell reports"
DOI: 10.1016/j.celrep.2017.07.006
Abstract: Combinatorial inhibition of effector and feedback pathways is a promising treatment strategy for KRAS mutant cancers. However, the particular pathways that should be targeted to optimize therapeutic responses are unclear. Using CRISPR/Cas9, we systematically mapped…
read more here.
Keywords:
mutant cancers;
therapeutic cooperativity;
landscape therapeutic;
cancers reveals ... See more keywords